Enhancing Functional Capacity in Older Adults With Short Session High Intensity Interval Training

NCT03750006 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2024-08-30

Study results available
· View outcomes & findings →

Summary

Frailty is a clinical condition of poor physiological reserve that increases risks for adverse health outcomes including falls, hospitalization and mortality. Exercise is beneficial for the prevention and even reversal of frailty, yet participation among older individuals is limited. Short session high intensity interval training (HIIT) is emerging as a promising exercise strategy that achieves performance gains with lower time commitment. The goal of this pilot proposal is to establish the feasibility of HIIT exercise training protocols in 65-85 year old individuals, as well as to demonstrate the ability to detect functional and physiologic benefits. The investigators anticipate the preliminary research findings will lay the foundation for future human clinical studies that will permit us to significantly improve the health of Veterans.

Conditions

Interventions

BEHAVIORAL

Short session HIIT

Individually tailored short session high intensity interval training session 3 times per week for 12 weeks on a recumbent exercise cycle.

Sponsors & Collaborators

  • The VA Western New York Healthcare System

    collaborator FED
  • University at Buffalo

    collaborator OTHER
  • Roswell Park Cancer Institute

    collaborator OTHER
  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Bruce R. Troen, MD · VA Western New York Healthcare System, Buffalo, NY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
60 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-12-03
Primary Completion
2021-12-31
Completion
2022-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03750006 on ClinicalTrials.gov